$SFES
SAFEGUARD SCIENTIFICS INC

2023 Q2 Form 10-Q Financial Statement

#000143774923012751 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.186M $1.185M
YoY Change 3.49% -3.97%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.186M $1.185M
YoY Change 3.49% -3.97%
Operating Profit -$1.186M -$1.185M
YoY Change 3.49% -3.97%
Interest Expense -$1.510M -$2.290M
YoY Change -194.43% -34.16%
% of Operating Profit
Other Income/Expense, Net -$166.0K -$9.000K
YoY Change -653.33% -99.55%
Pretax Income -$2.862M -$3.484M
YoY Change -692.55% -48.07%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.862M -$3.484M
YoY Change -692.55% -48.07%
Net Earnings / Revenue
Basic Earnings Per Share -$0.18 -$0.22
Diluted Earnings Per Share -$0.18 -$0.22
COMMON SHARES
Basic Shares Outstanding 16.31M 16.27M
Diluted Shares Outstanding 16.14K 16.07K

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.00M $18.80M
YoY Change -14.33% -3.13%
Cash & Equivalents $14.20M $11.00M
Short-Term Investments $800.0K $7.800M
Other Short-Term Assets $1.640M $1.370M
YoY Change -53.91% -60.76%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $16.73M $20.14M
YoY Change -20.6% -12.05%
LONG-TERM ASSETS
Property, Plant & Equipment $1.136M $1.215M
YoY Change -20.61% -18.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.43M $7.180M
YoY Change -44.69% -58.76%
Other Assets $247.0K $383.0K
YoY Change -7.49% 66.52%
Total Long-Term Assets $14.36M $13.59M
YoY Change -42.33% -41.68%
TOTAL ASSETS
Total Short-Term Assets $16.73M $20.14M
Total Long-Term Assets $14.36M $13.59M
Total Assets $31.08M $33.73M
YoY Change -32.37% -26.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $67.00K $71.00K
YoY Change 19.64%
Accrued Expenses $567.0K $539.0K
YoY Change 9.46% -2.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.256M $1.152M
YoY Change 9.98% 14.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $50.00K $50.00K
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $50.00K $50.00K
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.256M $1.152M
Total Long-Term Liabilities $50.00K $50.00K
Total Liabilities $2.319M $2.335M
YoY Change -12.92% -11.85%
SHAREHOLDERS EQUITY
Retained Earnings -$730.2M -$727.4M
YoY Change 2.01% 1.54%
Common Stock $803.5M $805.2M
YoY Change -0.51% -0.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.76M $31.39M
YoY Change
Total Liabilities & Shareholders Equity $31.08M $33.73M
YoY Change -32.37% -26.99%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.862M -$3.484M
YoY Change -692.55% -48.07%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.133M -$928.0K
YoY Change 3.19% -7.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $4.397M -$1.090M
YoY Change 2251.34% -64.86%
Cash From Investing Activities $4.397M -$1.090M
YoY Change 2251.34% -64.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -26.00K -$305.0K
YoY Change -97.36% -75.18%
NET CHANGE
Cash From Operating Activities -1.133M -$928.0K
Cash From Investing Activities 4.397M -$1.090M
Cash From Financing Activities -26.00K -$305.0K
Net Change In Cash 3.238M -$2.323M
YoY Change -270.69% -56.43%
FREE CASH FLOW
Cash From Operating Activities -$1.133M -$928.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2157000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2157000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
803021000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
804752000 usd
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
46379000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
48410000 usd
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19087
CY2023Q1 dei City Area Code
CityAreaCode
610
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
293-0600
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-727382000 usd
CY2023Q1 dei Security12b Title
Security12bTitle
common stock, par value $0.10
CY2023Q1 dei Trading Symbol
TradingSymbol
SFE
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-723898000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000 usd
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16307737
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11008000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13331000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000 usd
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7760000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5956000 usd
CY2023Q1 us-gaap Trading Securities
TradingSecurities
0 usd
CY2022Q4 us-gaap Trading Securities
TradingSecurities
860000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1345000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1251000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
20138000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21423000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1215000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1290000 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
11991000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
14545000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
383000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
434000 usd
CY2023Q1 us-gaap Assets
Assets
33727000 usd
CY2022Q4 us-gaap Assets
Assets
37692000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21573000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21573000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5310000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5478000
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2023Q1 sfe Long Term Incentive Plan Payments
LongTermIncentivePlanPayments
0 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
71000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
99000 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-5620
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-1609753
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
507000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
539000 usd
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
150 N. Radnor Chester Road
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
865000 usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Radnor
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
443000 usd
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
429000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1152000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1817000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1133000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1249000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2335000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3116000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31392000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34576000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33727000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37692000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1185000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1234000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1185000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1234000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1997000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
274000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
101000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2564000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3579000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3484000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6709000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3484000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6709000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16072
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16587
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16072
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16587
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-928000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1001000 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
850000 usd
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
298000 usd
CY2023Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
250000 usd
CY2022Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
3400000 usd
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
7690000 usd
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
-0 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
6000000 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1090000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3102000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
75000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
779000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
230000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
450000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-305000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1229000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2323000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5332000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13356000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24764000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11033000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19432000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34576000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3484000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
75000 usd
CY2023Q1 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
-207000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
168000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31392000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
50566000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6709000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
779000 usd
CY2022Q1 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
-303000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
168000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
43549000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11000000.0 usd
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
7800000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
7180000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
8846000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1317000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2177000 usd
CY2023Q1 us-gaap Advances To Affiliate
AdvancesToAffiliate
3494000 usd
CY2022Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
4382000 usd
CY2023Q1 sfe Investments And Advances To Affiliates Current And Noncurrent
InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent
11991000 usd
CY2022Q4 sfe Investments And Advances To Affiliates Current And Noncurrent
InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent
15405000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
292000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
314000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3484000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6709000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16072
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16587
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3484000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6709000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16072
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16587
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
CY2022Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16072
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16587
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
456000 usd
CY2023Q1 sfe Lessee Subleaseexpected Receipts Remainder Of Fiscal Year
LesseeSubleaseexpectedReceiptsRemainderOfFiscalYear
420000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
613000 usd
CY2023Q1 sfe Lessee Sublease Expected Receipts Year One
LesseeSubleaseExpectedReceiptsYearOne
573000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
619000 usd
CY2023Q1 sfe Lessee Subleaseexpected Receipts Year Two
LesseeSubleaseexpectedReceiptsYearTwo
590000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
207000 usd
CY2023Q1 sfe Lessee Subleaseexpected Receipts Year Three
LesseeSubleaseexpectedReceiptsYearThree
199000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2023Q1 sfe Lessee Subleaseexpected Receipts Year Four
LesseeSubleaseexpectedReceiptsYearFour
0 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
0 usd
CY2023Q1 sfe Lessee Subleaseexpected Receipts Year Five
LesseeSubleaseexpectedReceiptsYearFive
0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2023Q1 sfe Lessee Subleaseexpected Receipts Thereafter
LesseeSubleaseexpectedReceiptsThereafter
0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1895000 usd
CY2023Q1 sfe Lessee Sublease Expected Receipts Total
LesseeSubleaseExpectedReceiptsTotal
1782000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
319000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1576000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
0 usd
CY2023Q1 sfe Employee And Severance Agreement Maximum Aggregate Exposure
EmployeeAndSeveranceAgreementMaximumAggregateExposure
1000000.0 usd
CY2023Q1 sfe Employee And Severance Agreement Maximum Aggregate Exposure Shares
EmployeeAndSeveranceAgreementMaximumAggregateExposureShares
218750

Files In Submission

Name View Source Status
0001437749-23-012751-index-headers.html Edgar Link pending
0001437749-23-012751-index.html Edgar Link pending
0001437749-23-012751.txt Edgar Link pending
0001437749-23-012751-xbrl.zip Edgar Link pending
ex_463873.htm Edgar Link pending
ex_463874.htm Edgar Link pending
ex_463875.htm Edgar Link pending
ex_463876.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R9.htm Edgar Link pending
report.css Edgar Link pending
sfe-20230331.xsd Edgar Link pending
sfe20230331_10q.htm Edgar Link pending
Show.js Edgar Link pending
sfe-20230331_cal.xml Edgar Link unprocessable
sfe-20230331_lab.xml Edgar Link unprocessable
sfe-20230331_def.xml Edgar Link unprocessable
sfe-20230331_pre.xml Edgar Link unprocessable
sfe20230331_10q_htm.xml Edgar Link completed